01
iPS TECHNOLOGY
Model disease and evaluate candidates
Patient-derived iPS cells are differentiated into disease-relevant cells to reproduce human pathology and support target discovery, efficacy evaluation, and toxicity assessment.
- 01 PATIENT-DERIVED CELLS
Patient-derived cells
Disease information carried by patient cells forms the starting point of our research.
- 02 iPS TECHNOLOGY
Disease research with iPS cells
We derive disease-relevant cells and observe pathological processes at the cellular level.
- 03 DISEASE INSIGHT
Therapeutic insight
We deepen our understanding of disease and search for ways to act on its underlying causes.
- 04 THERAPEUTIC MODALITIES
Translation into therapeutic approaches
We connect scientific insight to gene therapies such as base editing that pursue fundamental treatment.
02
BASE EDITING
Repair a causal DNA variant
Base editing changes a selected nucleotide without making a DNA double-strand break, providing an approach to directly correct a disease-causing variant.
INFORMATION
About our research
Disease-model development and therapeutic candidate evaluation using patient-derived iPS cells are available for discussion as research services. Feasibility is assessed for each objective.